| Application no. and date | 12748646.2 (espacenet) (Federated) (European Patent Register), 20120706 | | Patent/reg. no. and date | DK/EP 2729470, 20170621 | | Publication date | 20140514 | | Priority no. and date | EP 11005587, 20110708 | | EP pub. no. and date |
EP 2729470 20140514 | | Effective date | | | Applicant/owner | Park Therapeutics, Inc., 2031 US Highway 130
Monmouth Junction, NJ 08852, US | | Applicant ref. no. | 160453 | | Inventor | KLUGE, Stefan, Lörracherstrasse 119
CH-4125 Riehen, DE,
PRÜHS, Stefan, Wiesenweg 10
69121 Heidelberg, DE,
GRUÃY, Michael, Hermannstrasse 8
52062 Aachen, DE | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/407 (2006.01) , A61P 29/00 (2006.01) , C07D 491/10 (2006.01) | | Title | Krystallinsk (1r,4r)-6'-fluor-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexan-1,1'-pyran[3,4,b]indol]-4-amin | | Int. application no. | EP2012002839 | | Int. publication no. | WO2013007361 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
